Autonomix Medical, Inc.(AMIX)
$1.08-0.02 (-1.82%)
AMIX
Autonomix Medical, Inc. financials statements
$1.08
At close:-0.02 (-1.82%)
Want to see AMIX full AI Analyst Report?
Autonomix Medical, Inc. (AMIX) Ratios
203 Followers
Autonomix Medical, Inc. Ratios
AMIX's free cash flow for Q2 2027 was $-2.62M. For the 2027 fiscal year, AMIX's free cash flow was decreased by $-7.00K and operating cash flow was $-2.61M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.45 | 5.63 | 12.09 | 3.91 | 22.02 |
| Quick Ratio | 4.45 | 5.63 | 12.09 | 3.91 | 22.02 |
| Cash Ratio | 4.11 | 5.35 | 11.08 | 3.91 | 21.92 |
| Solvency Ratio | -9.80 | -6.58 | -8.63 | -9.00 | 2.85 |
| Operating Cash Flow Ratio | -7.20 | -4.84 | -8.56 | -8.39 | -4.15 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 5.88M | $ 7.90M | $ 7.61M | $ 644.00K | $ 1.96M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.29 | 1.21 | 1.23 | 1.34 | 1.05 |
| Debt Service Coverage Ratio | 0.00 | -62.79 | -193.24 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -65.84 | -152.28 | 0.00 | -62.33 |
| Debt to Market Cap | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 2.09 | 1.48 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.41 | 0.83 | 0.50 | 0.43 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.13% | 98.46% | 128.23% | 100.00% | 98.05% |
| Return on Assets (ROA) | -219.93% | -116.36% | -163.98% | -230.06% | -649.31% |
| Return on Equity (ROE) | -283.55% | -140.88% | -202.23% | -309.01% | -680.21% |
| Return on Capital Employed (ROCE) | -288.96% | -143.08% | -139.40% | -309.01% | -693.76% |
| Return on Invested Capital (ROIC) | -288.96% | -143.08% | -139.40% | -309.01% | -693.76% |
| Return on Tangible Assets | -219.93% | -116.36% | -163.98% | -230.06% | -649.31% |
| Earnings Yield | -593.88% | -369.11% | -35.17% | -0.10% | -0.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -21291.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 21291.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -35.74 | -98.18 | -9.09 | -0.10 | -0.02 |
| Free Cash Flow Per Share | -35.77 | -98.34 | -9.12 | -0.10 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -1228.20 | -589.86 | -349.89 | -927199.00 | -129102.33 |
| Capital Expenditure Coverage Ratio | -1228.20 | -589.86 | -349.89 | -927199.00 | -129102.33 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -6.63 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -436.73% | -267.60% | -15.20% | -0.10% | -0.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.17 | -0.27 | -2.84 | -957.64 | -142.98 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.48 | 0.38 | 5.75 | 2959.18 | 972.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.23 | -0.37 | -6.58 | -1027.67 | -4920.38 |
| Price-to-Operating Cash Flow Ratio | -0.23 | -0.37 | -6.60 | -1027.67 | -4920.42 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | -0.00 | 11.33 | 0.00 |
| Enterprise Value Multiple | 0.25 | 0.55 | -2.37 | -957.21 | 0.00 |
| Enterprise Value | -4.19M | -6.04M | 36.25M | 1.90B | 1.90B |
| EV to EBITDA | 0.25 | 0.55 | -2.37 | -957.21 | 0.00 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.34 | 0.73 | -5.44 | -1027.20 | -4915.10 |
| EV to Operating Cash Flow | 0.34 | 0.73 | -5.45 | -1027.20 | -4915.14 |
| Tangible Book Value Per Share | 17.15 | 96.28 | 10.44 | 0.03 | 0.10 |
| Shareholders’ Equity Per Share | 17.15 | 96.28 | 10.44 | 0.03 | 0.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -48.64 | -135.65 | -21.10 | -0.11 | -0.71 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.98 | 1.02 | 1.01 | 1.00 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.73 | 0.72 | 0.43 | 0.93 | 0.03 |
Currency in USD

